Biodelivery Sciences International, INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersRaleigh, NC
US patents9
SAM.gov UEIYTXAH664PLW6
CAGE code548Q3
Incorporated inDE
Patents
9 US patents granted 2003–2018, none of them in the five years to SEP 2025.
Pharmaceuticals 9
- Transmucosal drug delivery devices for use in chronic pain reliefUS 9,901,539 · granted FEB 27, 2018
- Transmucosal delivery devices with enhanced uptakeUS 9,655,843 · granted MAY 23, 2017
- Transmucosal delivery devices with enhanced uptakeUS 9,597,288 · granted MAR 21, 2017
- Abuse resistant transmucosal drug delivery deviceUS 9,522,188 · granted DEC 20, 2016
- Abuse-resistant mucoadhesive devices for delivery of buprenorphineUS 8,703,177 · granted APR 22, 2014
Newest 5 shown · Granted to BioDelivery Sciences International, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Biodelivery Sciences International, INC | Raleigh | NC | — | LIKELY ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.